Market Analysis — CBHH- ROCHESTER
MN market | 3 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
1,234
Total Beds
$3.7B
Market Revenue
Competitive
HHI: nan
None
Moat Rating (2/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share0.0%
Top 3 Concentrationnan%
Network Density0.24
Margin vs Market+2.9%
Bed Util vs Market+29.7%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The MN market is competitive — many players, value creation must come from operations not market power (HHI: nan).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full MN market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| MAYO CLINIC HOSPITAL ROCHESTER | 1157 | $3,445M | 94.1% | 93.8% |
| OLMSTED MEDICAL CENTER | 61 | $218M | 5.9% | 4.9% |
Regional Payer Mix
■ Medicare 20%■ Medicaid 24%■ Commercial 56%